<p>Moody's Investors Service said on Thursday it expects India's economy to shrink by 8.9 per cent in the 2020 calendar year due to the <a href="https://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates.html" target="_blank">Covid-19</a> pandemic, compared to an earlier forecast of a 9.6 per cent contraction.</p>.<p>The revision comes as a rise in novel coronavirus cases slows in the world's second-most populous country, and economic activity picks up after a 23.9 per cent contraction in April-June, when consumer spending, private investments and exports collapsed during one of the world's strictest lockdowns.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/business/business-news/gdp-to-contract-86-in-q2-india-has-entered-recession-for-first-time-rbi-official-914481.html" target="_blank">GDP to contract 8.6% in Q2; India has entered recession for first time: RBI official</a></strong></p>.<p>"The steady decline in new and active (Covid-19) cases since September, if maintained, should enable further easing of restrictions. We, therefore, forecast a gradual improvement in economic activity over the coming quarters," Moody's said in a note.</p>.<p>In September, Moody's had forecast the economy to shrink by 9.6 per cent in the 2020 calendar year.</p>.<p>India is planning to announce a fresh round of stimulus totalling about $20 billion this week to help pull the economy out of its historic contraction, government officials told Reuters on Wednesday.</p>.<p>Finance Minister Nirmala Sitharaman is currently addressing the nation.</p>.<p><a href="https://www.deccanherald.com/business/nirmala-sitharaman-conference-live-finance-minister-economic-stimulus-indian-economy-package-relief-sector-narendra-modi-finance-ministry-914621.html" target="_blank"><strong>Nirmala Sitharaman press conference live on DH</strong></a></p>.<p>Separately, Goldman Sachs upgraded India to "overweight", citing a domestic macro recovery. It said Indian equities were most "positively sensitive to the improving prospects of a vaccine".</p>
<p>Moody's Investors Service said on Thursday it expects India's economy to shrink by 8.9 per cent in the 2020 calendar year due to the <a href="https://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates.html" target="_blank">Covid-19</a> pandemic, compared to an earlier forecast of a 9.6 per cent contraction.</p>.<p>The revision comes as a rise in novel coronavirus cases slows in the world's second-most populous country, and economic activity picks up after a 23.9 per cent contraction in April-June, when consumer spending, private investments and exports collapsed during one of the world's strictest lockdowns.</p>.<p><strong>Also read: <a href="https://www.deccanherald.com/business/business-news/gdp-to-contract-86-in-q2-india-has-entered-recession-for-first-time-rbi-official-914481.html" target="_blank">GDP to contract 8.6% in Q2; India has entered recession for first time: RBI official</a></strong></p>.<p>"The steady decline in new and active (Covid-19) cases since September, if maintained, should enable further easing of restrictions. We, therefore, forecast a gradual improvement in economic activity over the coming quarters," Moody's said in a note.</p>.<p>In September, Moody's had forecast the economy to shrink by 9.6 per cent in the 2020 calendar year.</p>.<p>India is planning to announce a fresh round of stimulus totalling about $20 billion this week to help pull the economy out of its historic contraction, government officials told Reuters on Wednesday.</p>.<p>Finance Minister Nirmala Sitharaman is currently addressing the nation.</p>.<p><a href="https://www.deccanherald.com/business/nirmala-sitharaman-conference-live-finance-minister-economic-stimulus-indian-economy-package-relief-sector-narendra-modi-finance-ministry-914621.html" target="_blank"><strong>Nirmala Sitharaman press conference live on DH</strong></a></p>.<p>Separately, Goldman Sachs upgraded India to "overweight", citing a domestic macro recovery. It said Indian equities were most "positively sensitive to the improving prospects of a vaccine".</p>